Notice

MAVIS edition 102

Marketing Authorisations Veterinary Information Service (MAVIS) edition 102

Document

Details

Content of MAVIS 102:

  • Pharmaceutical Industry Information Event on 23 June 2017
  • Restrictions on Schedule 6 (Exemptions for small pet animals) active substances
  • Guidance for applicants regarding applications to be submitted under Article 13
  • Marketing Authorisations
  • Quarterly reporting against VMD Published Standards for 2016-17 licensing work
  • Top Ten Imported Veterinary Medicines Quarterly Report from 1 January to 31 March 2017
  • Good Manufacturing Practice Inspection Team (GMPIT)
  • GMPIT inspection deficiency classification
  • GMPIT inspection deficiency findings 1 April 2016 to 31 March 2017
  • The Inspections and Investigations Team (IIT)
  • Changes to Wholesale Dealer Authorisation (WDA) application and variation forms
  • Pharmacovigilance quarterly report
  • Enforcement
  • Antimicrobial Resistance
  • Veterinary Products Committee
  • Residues controls and monitoring
  • Staff changes
  • VMD organogram as at 1 April 2017
Published 26 April 2017